T1	Intervention 0 8	Afatinib
T2	Intervention 16 28	methotrexate
T3	Intervention 448 456	Afatinib
T4	Intervention 596 604	afatinib
T5	Intervention 619 631	methotrexate
T6	Intervention 1316 1397	EGFR-targeted antibody therapy (but not EGFR-targeted tyrosine-kinase inhibitors)
T7	Intervention 1476 1551	oral afatinib (40 mg/day) or intravenous methotrexate (40 mg/m(2) per week)
T8	Intervention 2344 2352	afatinib
T9	Intervention 2364 2377	methotrexate.
T10	Intervention 2475 2487	the afatinib
T11	Intervention 2502 2518	the methotrexate
T12	Intervention 3046 3057	in 44 (14%)
T13	Intervention 3087 3102	and 18 (11%) of
T14	Intervention 3134 3148	INTERPRETATION
